HUMANA INC
HUMANA INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 4,951 | 4,200 | 5,388 | 4,040 | 4,250 | 2,221 | 5,116 | 5,501 | 5,910 | 4,694 | 15,148 | 16,214 | |||||
Assets Current | |||||||||||||||||
Assets Current | 38,080 | 32,733 | 32,752 | 33,615 | 34,422 | 29,815 | 32,926 | 32,858 | 32,796 | 29,986 | 38,253 | 38,759 | |||||
Receivables Net Current | 5,218 | 3,270 | 2,684 | 4,504 | 4,459 | 2,704 | 2,144 | 4,090 | 3,925 | 2,035 | 1,824 | 1,429 | |||||
Short Term Investments | 17,014 | 15,703 | 16,736 | 17,668 | 17,888 | 18,214 | 19,033 | 17,424 | 16,697 | 16,626 | 15,145 | 15,251 | |||||
Other Assets Current | 10,897 | 9,560 | 7,944 | 7,403 | 7,825 | 6,676 | 6,633 | 5,843 | 6,264 | 6,631 | 6,136 | 5,865 | |||||
Property Plant And Equipment Net | 2,170 | 2,231 | 2,268 | 2,356 | 2,427 | 2,532 | 2,693 | 2,821 | 2,979 | 3,030 | 3,342 | 3,309 | |||||
Available For Sale Securities Debt Securities Nonc… | 626 | 493 | 440 | 431 | 410 | 421 | 400 | 388 | 380 | 382 | 370 | 389 | |||||
Equity Method Investments | 633 | 638 | 623 | 636 | 659 | 697 | 729 | 736 | 730 | 740 | 762 | 733 | |||||
Goodwill | 10,489 | 9,686 | 9,619 | 9,633 | 9,631 | 9,631 | 9,590 | 9,567 | 9,563 | 9,550 | 9,540 | 9,539 | |||||
Other Assets Noncurrent | 3,282 | 3,128 | 4,017 | 3,686 | 3,381 | 3,383 | 3,669 | 3,723 | 3,643 | 3,377 | 3,638 | 3,726 | |||||
Assets | 55,280 | 48,909 | 49,719 | 50,357 | 50,930 | 46,479 | 50,007 | 50,093 | 50,091 | 47,065 | 55,905 | 56,455 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liability For Claims And Claims Adjustment Expense | 12,691 | 9,967 | 10,088 | 11,060 | 11,451 | 10,440 | 11,125 | 11,446 | 11,729 | 10,241 | 10,196 | 10,304 | |||||
Accounts Payable And Accrued Liabilities Current | 6,531 | 5,717 | 5,519 | 5,587 | 5,380 | 5,259 | 5,915 | 6,527 | 6,504 | 6,569 | 7,600 | 8,118 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 21,507 | 16,346 | 16,180 | 17,219 | 18,043 | 16,939 | 18,727 | 19,790 | 19,689 | 18,872 | 27,823 | 28,279 | |||||
Contract With Customer Liability Current | 269 | 356 | 265 | 274 | 265 | 260 | 195 | 313 | 301 | 266 | 7,536 | 7,378 | |||||
Debt Current | 1,719 | 0 | 0 | 0 | 577 | 577 | 1,136 | 1,149 | 822 | 1,443 | 2,245 | 2,022 | |||||
Long Term Debt Noncurrent | 12,274 | 12,369 | 12,607 | 12,586 | 12,729 | 11,144 | 11,886 | 11,746 | 12,390 | 10,213 | 9,483 | 9,722 | |||||
Other Liabilities Noncurrent | 2,853 | 2,457 | 2,350 | 2,257 | 2,339 | 1,951 | 1,770 | 1,829 | 1,826 | 1,662 | 1,595 | 1,563 | |||||
Liabilities | 36,634 | 31,172 | 31,137 | 32,062 | 33,111 | 30,034 | 32,383 | 33,365 | 33,905 | 30,747 | 38,901 | 39,564 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital Common Stock | 3,641 | 3,600 | 3,639 | 3,557 | 3,497 | 3,463 | 3,471 | 3,420 | 3,369 | 3,346 | 3,362 | 3,313 | |||||
Stockholders Equity | 18,646 | 17,657 | 18,522 | 18,234 | 17,751 | 16,375 | 17,624 | 16,671 | 16,186 | 16,262 | 17,004 | 16,834 | |||||
Retained Earnings Accumulated Deficit | 30,153 | 29,075 | 29,980 | 29,891 | 29,453 | 28,317 | 29,118 | 28,745 | 28,173 | 27,540 | 28,191 | 27,468 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -731 | -633 | -666 | -783 | -868 | -1,067 | -653 | -1,122 | -1,086 | -999 | -1,503 | -1,226 | |||||
Treasury Stock Common Value | -14,516 | -14,418 | -14,464 | -14,464 | -14,364 | -14,371 | -14,404 | -14,405 | -14,359 | -13,658 | -13,134 | -12,754 | |||||
Minority Interest | 66 | 80 | 60 | 61 | 68 | 70 | 59 | 57 | 56 | 56 | 55 | 57 | |||||
Liabilities And Stockholders Equity | 55,280 | 48,909 | 49,719 | 50,357 | 50,930 | 46,479 | 50,007 | 50,093 | 50,091 | 47,065 | 55,905 | 56,455 | |||||
Allowance For Doubtful Accounts Receivable Current | 102 | 108 | 124 | 143 | 121 | 98 | 93 | 96 | 85 | 88 | 73 | 72 | |||||
Preferred Stock Par Or Stated Value Per Share | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.167 | 0.17 | 0.167 | 0.167 | 0.167 | 0.17 | 0.167 | 0.167 | 0.167 | 0.17 | 0.167 | 0.167 | |||||
Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 199 | 199 | 199 | 199 | 199 | 199 | 199 | 199 | 199 | 199 | 199 | 199 | |||||
Treasury Stock Common Shares | 79 | 78 | 78 | 78 | 78 | 78 | 78 | 78 | 78 | 76 | 76 | 75 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 26.67% | 48.34% | 64.92% | - | - | - | - | - | - | - | - | - |
| 2025 | -14.23% | -8.63% | -15.64% | 14.55% | -3.37% | 5.55% | -7.24% | -1.97% | 0.93% | -13.16% | 1.38% | 45.07% |
| 2024 | 12.73% | 13.59% | 21.26% | -2.41% | -14.16% | -25.92% | 11.94% | -7.22% | 6.49% | -6.79% | 9.11% | -7.72% |
| 2023 | - | - | - | -0.99% | 2.13% | 7.92% | 5.91% | -7.39% | -17.79% | -6.77% | -13.76% | -11.71% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.77 | 2.00 | 2.02 | 1.95 | 1.91 | 1.76 | 1.76 | 1.66 | 1.67 | 1.59 | 1.37 | 1.37 | |||||
| Quick Ratio | 1.77 | 2.00 | 2.02 | 1.95 | 1.91 | 1.76 | 1.76 | 1.66 | 1.67 | 1.59 | 1.37 | 1.37 | |||||
| Working Capital | 16.57B | 16.39B | 16.57B | 16.40B | 16.38B | 12.88B | 14.20B | 13.07B | 13.11B | 11.11B | 10.43B | 10.48B | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 1.96 | 1.76 | 1.68 | 1.75 | 1.86 | 1.83 | 1.84 | 1.99 | 2.09 | 1.88 | 2.29 | 2.34 | |||||
| Interest Coverage TTM | 3.68 | 4.29 | 4.57 | 5.07 | 5.05 | 3.88 | 4.29 | 5.51 | 6.55 | 8.14 | 9.86 | 10.05 | |||||
| Debt Ratio | 0.66 | 0.64 | 0.63 | 0.64 | 0.65 | 0.65 | 0.65 | 0.67 | 0.68 | 0.65 | 0.70 | 0.70 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.12 | 0.12 | 0.11 | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 | 0.08 | 0.09 | 0.07 | 0.08 | |||||
| Days Sales Outstanding TTM | 285.95 | 186.91 | 160.20 | 313.49 | 325.34 | 195.19 | 168.21 | 238.79 | 313.32 | 167.84 | 156.75 | 211.51 | |||||
| Receivables Turnover TTM | 1.28 | 1.95 | 2.28 | 1.16 | 1.12 | 1.87 | 2.17 | 1.53 | 1.16 | 2.17 | 2.33 | 1.73 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 9.37 | 9.83 | 10.72 | 13.08 | 14.17 | 9.99 | 11.27 | 14.18 | 16.40 | 20.00 | 24.25 | 26.94 | |||||
| Free Cash Flow Per Share TTM | 10.57 | 3.11 | 12.86 | 20.23 | 19.73 | 19.83 | -36.08 | -41.96 | -26.79 | 24.03 | 40.45 | 97.44 | |||||
| Dividend Per Share TTM | 3.57 | 3.57 | 3.57 | 3.56 | 3.56 | 3.57 | 3.60 | 3.62 | 3.64 | 3.48 | 3.41 | 3.31 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | -1,810.36% | -1,799.74% | -1,854.04% | -1,990.77% | -2,070.42% | -1,608.40% | -1,072.22% | -503.56% | 86.84% | 87.78% | 88.62% | 89.30% | |||||
| Operating Profit Margin TTM | 39.57% | 46.36% | 53.98% | 65.90% | 71.02% | 57.82% | 64.04% | 76.70% | 86.18% | 99.50% | 112.21% | 107.51% | |||||
| Net Profit Margin TTM | 18.30% | 20.37% | 23.53% | 31.56% | 36.40% | 27.24% | 31.61% | 40.56% | 48.56% | 61.72% | 75.23% | 81.40% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 31.32% | 31.64% | 27.76% | 18.61% | 14.82% | 9.87% | 7.71% | 1.88% | -9.20% | -15.56% | -20.46% | -12.12% | |||||
| Net Income Growth (1Y) | -34.00% | -1.57% | -4.92% | -7.71% | -13.93% | -51.51% | -54.74% | -49.23% | -36.07% | -11.17% | 7.13% | 7.15% | |||||
| EPS Growth (1Y) | -33.81% | -1.48% | -4.82% | -7.79% | -13.70% | -50.18% | -53.60% | -47.49% | -33.94% | -9.34% | 9.86% | 8.83% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 18.42 | 25.78 | 23.92 | 18.40 | 18.32 | 24.81 | 27.34 | 25.59 | 20.47 | 22.05 | 19.29 | 15.94 | |||||
| P/B TTM | 1.12 | 1.73 | 1.67 | 1.59 | 1.76 | 1.82 | 2.11 | 2.62 | 2.51 | 3.36 | 3.41 | 3.18 | |||||
| P/S TTM | 3.37 | 5.25 | 5.63 | 5.81 | 6.67 | 6.76 | 8.64 | 10.38 | 9.94 | 13.61 | 14.51 | 12.97 | |||||
| Market Cap | 20.82B | 30.62B | 30.95B | 29.05B | 31.36B | 29.95B | 37.20B | 43.78B | 40.71B | 54.89B | 58.01B | 53.71B | |||||
| Enterprise Value | 29.86B | 38.79B | 38.17B | 37.60B | 40.41B | 39.45B | 45.11B | 51.17B | 48.01B | 61.85B | 54.59B | 49.24B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 1.27B | 375.00M | 1.55B | 2.44B | 2.38B | 2.39B | -4.34B | -5.05B | -3.24B | 2.98B | 4.99B | 12.14B | |||||
| Net Debt | 9.04B | 8.17B | 7.22B | 8.55B | 9.06B | 9.50B | 7.91B | 7.39B | 7.30B | 6.96B | -3.42B | -4.47B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
HUMANA INC (HUM) — SEC Financial Statements & Analysis
HUMANA INC (HUM) is a hospital & medical service plans company, incorporated in DE. HUMANA INC trades on NYSE as: HUM. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), HUMANA INC reported a 31.32% year-over-year revenue growth, a Gross Profit Margin of -1810.36% (TTM), a Debt-to-Equity ratio of 1.96x, a Price-to-Sales (P/S) ratio of 3.37x (TTM), a Price-to-Book (P/B) ratio of 1.12x (TTM), at a market cap of $20.82B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 31.32%
- Gross Profit Margin TTM
- -1810.36%
- Debt To Equity
- 1.96x
- P/S TTM
- 3.37x
- P/B TTM
- 1.12x
- Market Cap
- $20.82B
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is HUMANA INC in?
HUMANA INC (HUM) operates in the Hospital & Medical Service Plans industry.
What is HUM's market cap?
HUMANA INC (HUM) has a market capitalization of $20.82B as of 2026-03-31.
What is HUM's P/E ratio?
HUMANA INC (HUM)'s trailing twelve month P/E ratio is 18.42x as of 2026-03-31.
What exchange does HUM trade on?
HUMANA INC (HUM) trades on the NYSE.
Where is HUMANA INC incorporated?
HUMANA INC is incorporated in DE.